Efficacy and safety of combined use of docetaxel- gemcitabine chemotherapy and 5-fluorouracil targeted therapy in the treatment of advanced non-small cell lung cancer

HIGHLIGHTS

  • who: Prof Patrick O Erah from the Department of Pharmacy, Department of Medical Oncology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China have published the research: Efficacy and safety of combined use of docetaxel- gemcitabine chemotherapy and 5-fluorouracil targeted therapy in the treatment of advanced non-small cell lung cancer, in the Journal: (JOURNAL)
  • what: In this study, data were analyzed with SPSS21.0 software, while graphics were done with GraphPad Prism 7 software (GraphPad Software, San Diego, USA).

SUMMARY

    Lung cancer is a malignant . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?